IMRE Corp said it completed a privateplacement of about 400,000 shares of its securities with agroup of European institutions for 2.5 mln dlrs.    The company said proceeds will be used for working capitaland to implement the company's business plan.    IMRE also said it has established a light manufacturingfacility in Richmond, Washington that makes raw materialcomponents for Prosorba column, a medical device that removesdisease-related immune components from the human bloodstream.    The company is awaiting Food and Drug Administrationapproval on the device. Reuter&#3;